WALTHAM, Mass.--(BUSINESS WIRE)--Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that its Lincoln Safety Group’s Clinical Trials Signal Detection (CTSD™) product garnered a prestigious “Best Practices” award at the recent Bio-IT World Life Sciences Conference and Expo in Boston. Today’s announcement marks the second time in three years CTSD has been honored by the conference and expo; in 2006, CTSD took home a Best of Show award.
